Catalyst Pharmaceutical CPRX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's short- and long-term operating lease liabilities?
- Catalyst Pharmaceutical (CPRX) reported short- and long-term operating lease liabilities of -$106K in Q1 2026.
- How has Catalyst Pharmaceutical's short- and long-term operating lease liabilities changed year-over-year?
- Catalyst Pharmaceutical's short- and long-term operating lease liabilities decreased by 9.3% year-over-year, from -$97K to -$106K.
- What is the long-term trend for Catalyst Pharmaceutical's short- and long-term operating lease liabilities?
- Over 3 years (2022 to 2025), Catalyst Pharmaceutical's short- and long-term operating lease liabilities has grown at a 9.3% compound annual growth rate (CAGR), from -$307K to -$401K.